Patents by Inventor Shirou Mawatari

Shirou Mawatari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cerebral nerve cell neogenesis agent
    Patent number: 8822437
    Abstract: An objective of the present invention is to provide a new substance having a cerebral nerve cell neogenesis effect. Another objective is to provide a cerebral nerve cell neogenesis agent that is effective in treating and/or preventing neurological disorders utilizing the substance. With the present invention, a cerebral nerve cell neogenesis agent containing a plasmalogen as an active ingredient is provided. In particular, a preferable cerebral nerve cell neogenesis agent contains, as an active ingredient, a biological tissue (preferably, an avian tissue) extracted plasmalogen mainly including an ethanolamine plasmalogen and a choline plasmalogen.
    Type: Grant
    Filed: January 6, 2011
    Date of Patent: September 2, 2014
    Assignee: Marudai Food Co., Ltd.
    Inventors: Masataka Ifuku, Takehiko Fujino, Shirou Mawatari, Masaaki Sugiyama, Yoshirou Kodama, Hidetaka Fuchu, Keita Yunoki
  • DRUG AGAINST CENTRAL NERVOUS SYSTEM INFLAMMATION
    Publication number: 20130172293
    Abstract: An objective of the present invention is to provide a novel method with an effect of alleviating central nervous system inflammation. The present invention provides a drug against central nervous system inflammation containing a plasmalogen. More preferably, the present invention provides a drug against central nervous system inflammation containing a plasmalogen extracted from a biological tissue (preferably an avian tissue) that mainly contains an ethanolamine plasmalogen and a choline plasmalogen.
    Type: Application
    Filed: September 22, 2011
    Publication date: July 4, 2013
    Applicants: FUJINO BRAIN RESEARCH CO.,LTD., UMEDA JIMUSHO LTD., MARUDAI FOOD CO., LTD.
    Inventors: Shirou Mawatari, Takehiko Fujino, Masataka Ifuku, Masaaki Sugiyama, Hidetaka Fuchu
  • CEREBRAL NERVE CELL NEOGENESIS AGENT
    Publication number: 20120283223
    Abstract: An objective of the present invention is to provide a new substance having a cerebral nerve cell neogenesis effect. Another objective is to provide a cerebral nerve cell neogenesis agent that is effective in treating and/or preventing neurological disorders utilizing the substance. With the present invention, a cerebral nerve cell neogenesis agent containing a plasmalogen as an active ingredient is provided. In particular, a preferable cerebral nerve cell neogenesis agent contains, as an active ingredient, a biological tissue (preferably, an avian tissue) extracted plasmalogen mainly including an ethanolamine plasmalogen and a choline plasmalogen.
    Type: Application
    Filed: January 6, 2011
    Publication date: November 8, 2012
    Inventors: Masataka Ifuku, Takehiko Fujino, Shirou Mawatari, Masaaki Sugiyama, Yoshirou Kodama, Hidetaka Fuchu, Keita Yunoki